EU approves HIV treatment

London - The pharmaceuticals giant GlaxoSmithKline was yesterday given the go-ahead to market its HIV treatment Trizivir in EU…

London - The pharmaceuticals giant GlaxoSmithKline was yesterday given the go-ahead to market its HIV treatment Trizivir in EU member countries.

The medicine is the first of its kind to combine the anti-HIV therapies abacavir sulphate, lamivudine and zidovudine in one tablet.

  • Join The Irish Times on WhatsApp and stay up to date

  • Sign up for push alerts to get the best breaking news, analysis and comment delivered directly to your phone

  • Listen to In The News podcast daily for a deep dive on the stories that matter